Achieves alignment with U.S. Food and Drug Administration (FDA) on regulatory path for potential accelerated approval of iopofosine I 131 as a ...

Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today ...

The company's product pipeline includes its lead assets: iopofosine I 131, a PDC designed to provide targeted delivery of iodine-131 (radioisotope); CLR 121225, an actinium-225 based program being ...

If the bomb detonated at or near ground level, a towering mushroom cloud would form, sucking up soil, steel, concrete, and ...

DEAR, It is sobering to learn that, fourteen years after the Fukushima-Daiichi nuclear disaster in Japan, the three destroyed ...

This March, celebrate National Nutrition Month® by raising a glass of cold milk. Count on dairy to bring together a wide ...

The web browser is arguably the most important piece of software on your computer. You spend much of your time online inside a browser: when you search, chat, email ...

Anaphylactoid and delayed cell-mediated unwanted effects are common; rare adverse reactions include iodine-related sialadenopathy, iododerma, and acneiform eruptions. To describe the occurrence of ...

Neoadjuvant Therapy for Men with High Risk Disease Prior to Prostatectomy - Mary-Ellen Taplin ...